Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Depression

Free Subscription Articles published in BMJ Retrieve available abstracts of 35 articles: HTML format

Single Articles

October 2025
1. DOSHI P
   Notorious GSK paroxetine adolescent depression trial is slapped with expression of concern amid legal action.
   BMJ. 2025;391:r2279.
   PubMed    
   
   
   
2. MAHASE E
   Sertraline study shows mixed effect on depression symptoms.
   BMJ. 2025;391:r2294.
   PubMed    
   
   
   
3. TAYLOR L
   WHO: Third of European doctors and nurses have depression or anxiety.
   BMJ. 2025;391:r2156.
   PubMed    
   
   
   September 2025
4. 
   Medical news in brief: Surgeon is jailed for amputation fraud, first pill for postnatal depression, Ebola in DRC, and other stories.
   BMJ. 2025;390:r1892.
   PubMed    
   
   
   August 2025
5. BOWIE K
   Postnatal depression: First pill treatment is approved in UK.
   BMJ. 2025;390:r1826.
   PubMed    
   
   
   
6. DEAN E
   "I was suicidal"-the consultant psychiatrist opening up the conversation on postnatal depression.
   BMJ. 2025;390:r1449.
   PubMed    
   
   
   July 2025
7. ARETOULI E, Malik M, Widmann C, Parker AM, et al
   Cognitive and mental health outcomes in long covid.
   BMJ. 2025;390:e081349.
   PubMed     Abstract available
   
   
   April 2025
8. FRAIS T
   Finding the right treatment for severe depression.
   BMJ. 2025;389:r478.
   PubMed    
   
   
   February 2025
9. 
   CORRECTION: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.
   BMJ. 2025;388:r111.
   PubMed    
   
   
   October 2024
10. NOLAN T
    CBT for postnatal depression ... and other research.
    BMJ. 2024;387:q2308.
    PubMed    
    
    
    September 2024
11. HAUN MW, Tonnies J, Hartmann M, Wildenauer A, et al
    Model of integrated mental health video consultations for people with depression or anxiety in primary care (PROVIDE-C): assessor masked, multicentre, randomised controlled trial.
    BMJ. 2024;386:e079921.
    PubMed     Abstract available
    
    
    August 2024
12. ZHANG Y, Wang H, Wu S, Xiao Y, et al
    Empowering new mothers in China: role of paediatric care in screening and management of postpartum depression.
    BMJ. 2024;386:e078636.
    PubMed    
    
    
    
13. HSU TW, Tsai CK, Kao YC, Thompson T, et al
    Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.
    BMJ. 2024;386:e078607.
    PubMed     Abstract available
    
    
    
14. WISE J
    Sixty seconds on . . . antidepression headsets.
    BMJ. 2024;386:q1784.
    PubMed    
    
    
    July 2024
15. NJENGA C, Ramanuj PP, de Magalhaes FJC, Pincus HA, et al
    New and emerging treatments for major depressive disorder.
    BMJ. 2024;386:e073823.
    PubMed     Abstract available
    
    
    June 2024
16. IACOBUCCI G
    Stopping antidepressants causes symptoms in one in six people, study estimates.
    BMJ. 2024;385:q1246.
    PubMed    
    
    
    May 2024
17. 
    Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2024;385:q1024.
    PubMed    
    
    
    
18. 
    EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.
    BMJ. 2024;385:q1025.
    PubMed    
    
    
    
19. METAXA AM, Clarke M
    Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.
    BMJ. 2024;385:e078084.
    PubMed     Abstract available
    
    
    
20. DE GIORGI R, Ede R
    Psilocybin for depression.
    BMJ. 2024;385:q798.
    PubMed    
    
    
    April 2024
21. WANG S, Deng CM, Zeng Y, Chen XZ, et al
    Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial.
    BMJ. 2024;385:e078218.
    PubMed     Abstract available
    
    
    March 2024
22. FABIANO NT
    The effect of exercise on suicide in people with depression.
    BMJ. 2024;384:q609.
    PubMed    
    
    
    February 2024
23. BELLON JA
    Exercise for the treatment of depression.
    BMJ. 2024;384:q320.
    PubMed    
    
    
    
24. NOETEL M, Sanders T, Gallardo-Gomez D, Taylor P, et al
    Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2024;384:e075847.
    PubMed     Abstract available
    
    
    
25. RUSSELL AB, Slater J, Woods N
    Regulation of the illicit drugs industry will save lives and reduce misery.
    BMJ. 2024;384:q304.
    PubMed    
    
    
    
26. STUPAK R
    Reversing the rate of antidepressant prescribing: a view from Poland.
    BMJ. 2024;384:q234.
    PubMed    
    
    
    January 2024
27. HAGATULAH N, Brann E, Oberg AS, Valdimarsdottir UA, et al
    Perinatal depression and risk of mortality: nationwide, register based study in Sweden.
    BMJ. 2024;384:e075462.
    PubMed     Abstract available
    
    
    
28. BRANN E, Shen Q, Lu D
    Perinatal depression and its health impact.
    BMJ. 2024;384:p2777.
    PubMed    
    
    
    December 2023
29. DAVIES J, Read J, Kruger D, Crisp N, et al
    Politicians, experts, and patient representatives call for the UK government to reverse the rate of antidepressant prescribing.
    BMJ. 2023;383:p2730.
    PubMed    
    
    
    September 2023
30. CHEN CC, Shao J, Liu Y, Gao Y, et al
    A man with ST segment depression.
    BMJ. 2023;382:e076079.
    PubMed    
    
    
    August 2023
31. MAHASE E
    US approves daily pill for postpartum depression.
    BMJ. 2023;382:p1822.
    PubMed    
    
    
    July 2023
32. THOMBS BD, Markham S, Rice DB, Ziegelstein RC, et al
    Screening for depression and anxiety in general practice.
    BMJ. 2023;382:1615.
    PubMed    
    
    
    
33. NOGRADY B
    Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics.
    BMJ. 2023;382:p1599.
    PubMed    
    
    
    June 2023
34. WISE J
    Review that questioned serotonin theory of depression was flawed, say researchers.
    BMJ. 2023;381:1419.
    PubMed    
    
    
    March 2023
35. IACOBUCCI G
    NICE recommends online therapies to treat depression and anxiety in adults.
    BMJ. 2023;380:p495.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Depression is free of charge.